Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Brière
Outcome of Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Fail Second-Line Salvage Regimens in the International CORAL Study
Bone Marrow Transplantation
Transplantation
Hematology
Human Herpes Virus 8 (Kaposi’s Sarcoma Herpes Virus) and Malignant Lymphoproliferations in France: A Molecular Study of 250 Cases Including Two AIDS-associated Body Cavity Based Lymphomas
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies
Oncologist
Cancer Research
Medicine
Oncology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Population Pharmacokinetics of Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Association With Clinical Outcome
British Journal of Clinical Pharmacology
Pharmacology
Diffuse Large B-Cell Lymphoma
Outcomes of Diffuse Large B-Cell Lymphoma Patients Relapsing After Autologous Stem Cell Transplantation: An Analysis of Patients Included in the CORAL Study
Bone Marrow Transplantation
Transplantation
Hematology
Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Primary Breast Diffuse Large B-Cell Lymphoma. Clinical Features and Outcome in 55 Patients. Polish Lymphoma Research Group Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma
American Journal of Hematology
Hematology